Bio-Rad Laboratories, Inc. BIO.B Asia Pacific — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s asia pacific — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s asia pacific — net sales?
- Bio-Rad Laboratories, Inc. (BIO.B) reported asia pacific — net sales of $110.4M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s asia pacific — net sales changed year-over-year?
- Bio-Rad Laboratories, Inc.'s asia pacific — net sales increased by 6.1% year-over-year, from $104.1M to $110.4M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s asia pacific — net sales?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s asia pacific — net sales has grown at a -7.1% compound annual growth rate (CAGR), from $688.4M to $513.3M.
- What does asia pacific — net sales mean?
- This metric represents the total revenue generated from the sale of clinical diagnostics and life science products within the Asia Pacific geographic region. It reflects the company's market penetration, demand for research and diagnostic solutions, and overall commercial success in these specific international markets. Tracking this figure helps investors assess the company's geographic diversification and growth momentum in emerging and established Asian economies.